Q2

JLL Partners Announces Investment in Vascular Technology, Incorporated

JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, announces its investment in Vascular Technology, Incorporated (“VTI” or the “Company”), a medical device company specializing in innovative surgical devices and single-use consumables for the operating room. Founded

JLL Partners Announces Investment in Vascular Technology, Incorporated Read More »

HealthpointCapital Acquires ImmersiveTouch, Inc., a Leading Extended Reality Surgical Platform

HealthpointCapital, the leading private equity firm focused exclusively on musculoskeletal healthcare, announces the acquisition of a majority stake in ImmersiveTouch, Inc. (“ImmersiveTouch” or the “Company”). ImmersiveTouch’s ImmersiveView™ platform is a patented, proprietary Virtual Reality (VR) and Augmented Reality (AR) software solution for surgical planning, navigation and patient-customized surgical guides. Currently focused on facial and thoracic

HealthpointCapital Acquires ImmersiveTouch, Inc., a Leading Extended Reality Surgical Platform Read More »

AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announces that it has closed on the previously disclosed disposition of certain infusion assets in its Wellness at Home segment to a third party. The products included in the disposition

AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt Read More »

USpharma Ltd. Secures Growth Capital Investment by 1315 Capital

USpharma Ltd., a pharmaceutical development and manufacturing company commercializing several novel delivery platforms, announces a significant growth equity investment by 1315 Capital, a Philadelphia-based healthcare growth equity firm. USpharma leverages advanced and patented formulation technologies, including its next generation soft chewable dosage forms and the unique capabilities of its 150,000 square foot US-based GMP facility,

USpharma Ltd. Secures Growth Capital Investment by 1315 Capital Read More »

OneOncology and Hematology Oncology Associates of the Treasure Coast to Enhance Cancer Care on Florida’s Treasure Coast and Surrounding Areas

OneOncology, a physician-led national platform empowering independent oncology practices, and Hematology Oncology Associates of the Treasure Coast (HOATC), a physician-owned oncology practice with six physicians treating patients at four state-of-the-art clinics located throughout St. Lucie & Martin Counties, have finalized a partnership agreement that will enhance the delivery of cancer care services across the Treasure

OneOncology and Hematology Oncology Associates of the Treasure Coast to Enhance Cancer Care on Florida’s Treasure Coast and Surrounding Areas Read More »

Scroll to Top